Inventor
KOCHENDERFER JAMES N
US30 patents
⚠️ This page may combine multiple inventors who share the name “KOCHENDERFER JAMES N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
22 patentsUS10287350B2May 14, 2019
Chimeric antigen receptors targeting CD-19
US HEALTH39 citations98
US11377660B2Jul 5, 2022
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH7 citations94
US11359204B2Jun 14, 2022
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH7 citations94
US10767184B2Sep 8, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH11 citations94
US11066674B2Jul 20, 2021
Chimeric antigen receptors targeting b-cell maturation antigen
US HEALTH6 citations92
US10900042B2Jan 26, 2021
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH8 citations92
US10876123B2Dec 29, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH8 citations92
US10844387B2Nov 24, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH8 citations92
US10837019B2Nov 17, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH7 citations92
US10829769B2Nov 10, 2020
Chimeric antigen receptors targeting b-cell maturation antigen
US HEALTH7 citations92
US10829768B2Nov 10, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH7 citations92
US10829767B2Nov 10, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH7 citations92
US10815487B2Oct 27, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH8 citations92
US10815488B2Oct 27, 2020
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH8 citations92
US11827889B2Nov 28, 2023
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH4 citations86
US10815301B2Oct 27, 2020
Anti-CD30 chimeric antigen receptors
US HEALTH15 citations86
US12180484B2Dec 31, 2024
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH1 citations73
US11773396B2Oct 3, 2023
Chimeric antigen receptors targeting B-cell maturation antigen
US HEALTH1 citations73
US11236161B2Feb 1, 2022
Chimeric antigen receptors targeting CD-19
US HEALTH4 citations73
US11951131B2Apr 9, 2024
Anti-SLAMF7 chimeric antigen receptors
US HEALTH4 citations72
US12473359B2Nov 18, 2025
Chimeric antigen receptors targeting CD-19
US HEALTH0 citations62
US12570717B2Mar 10, 2026
Anti-B-cell maturation antigen chimeric antigen receptors with human domains
US HEALTH0 citations57
KITE PHARMA INC
6 patentsUS9855298B2Jan 2, 2018
Methods of conditioning patients for T cell therapy
KITE PHARMA INC80 citations96
US10322146B2Jun 18, 2019
Methods of conditioning patients for T cell therapy
KITE PHARMA INC17 citations92
US11779601B2Oct 10, 2023
Diagnostic methods for T cell therapy
KITE PHARMA INC5 citations73
US11491187B2Nov 8, 2022
Methods of conditioning patients for T cell therapy
KITE PHARMA INC2 citations71
US12559718B2Feb 24, 2026
Diagnostic methods for t cell therapy
KITE PHARMA INC0 citations61
US12458654B2Nov 4, 2025
Methods of conditioning patients for T cell therapy
KITE PHARMA INC0 citations58